EBSCO Logo
Connecting you to content on EBSCOhost
Results
Title

Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Neutralization After Antenatal Messenger RNA Vaccination.

Authors

Rottenstreich, Amihai; Vorontsov, Olesya; Alfi, Or; Zarbiv, Gila; Oiknine-Djian, Esther; Zigron, Roy; Kleinstern, Geffen; Mandelboim, Michal; Porat, Shay; Wolf, Dana G

Abstract

We evaluated the neutralization efficiency against SARS-CoV-2 Omicron variant in maternal and cord blood sera after antenatal BNT162b2 vaccination. Neutralizing antibodies against Omicron were lacking at the time of delivery after 2-dose vaccination. A third booster dose was essential in building neutralizing antibody capacity against Omicron among mothers and neonates.

Subjects

SARS-CoV-2; IMMUNIZATION; MATERNAL-fetal exchange; COVID-19 vaccines; GENETIC variation; CORD blood; NEUTRALIZATION tests; PRENATAL care; VIRAL antibodies; DELIVERY (Obstetrics)

Publication

Clinical Infectious Diseases, 2022, Vol 75, Issue 11, p2023

ISSN

1058-4838

Publication type

Academic Journal

DOI

10.1093/cid/ciac395

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved